Stocktoria

Tectonic Therapeutic, Inc. TECX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-21

Tectonic Therapeutic, Inc. statistics & valuation

Market cap$603.6M
P / B2.4×
Return on equity-29.5%
Return on capital-33.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
201720182019202020212022202320242025
Return on equity (%)
-37.90% -39.20% -47.10% -70.30% -41.20% -29.50% 201720182019202020212022202320242025
Shares outstanding
2.3M 23.8M 31.6M 43.7M 43.7M 43.9M 1.4M 14.9M 18.7M 201720182019202020212022202320242025
Net debt ($)
-$174.6M -$77.6M 201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-265.60% -34.70% -36.40% -44.10% -58.40% -101.90% -108.70% -37.90% -28.40% 201720182019202020212022202320242025
Free cash flow margin (%)
201720182019202020212022202320242025
Debt / equity (×)
0.09× 201720182019202020212022202320242025
EPS ($)
-$2.78 -$2.42 -$33.76 -$6.83 -$4.05 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-28.4%-37.9%-108.7%-101.9%-58.4%-44.1%-36.4%-34.7%-265.6%
Return on equity-29.5%-41.2%50.6%231.9%-70.3%-47.1%-39.2%-37.9%80.6%
Debt / equity———-0.33×0.09×————
Current ratio26.6312.650.767.6210.2716.0913.9612.262.40

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.